Go
ABOUT US
Overview
Company profile
Vision mission and values
Group companies
Businesses
Leadership
- Board
- Key management
Milestones
Innovation
Awards
Tata code of conduct
NCourage
GEOGRAPHIES
Overview
Asia
India
Company profile
Products
Community
Working with us
Newsroom
Facilities
NCourage
Singapore
North America
About Us
Company profile
Working with us
Products
Facilities
Newsroom
Europe
About us
Products
Community
Working with us
Newsroom
British Salt
Modern slavery compliance statement
Magadi
About us
Products
Community
Working with us
Newsroom
Facilities
Trona
South Africa
About us
Products
Services
Our Facilities
PRODUCTS
Overview
Asia
Basic Chemistry Products
- Soda ash
- Allied chemicals
- Sodium bicarbonate
- Cement
Specialty Products
- Agri Sciences
- Nutritional Sciences
- Material Sciences
North America
Basic Chemistry products
- Dense soda ash
- Natural light soda ash
- Synthetic light soda ash
Europe
Basic Chemistry Products
- Heavy Soda Ash (Sodium Carbonate)
- Light Soda Ash (Sodium Carbonate)
- Sodium Bicarbonate
- Sodium Chloride
- Crex
- Calcium Chloride
- Energy
Magadi
Our Production
- Dense soda ash sodium carbonate
- Crushed Refined Soda
- Livestock salt
- Dry industrial salt
South Africa
Basic Chemistry Products
- High Purity Soda Ash (HP)
- Crushed Refined Soda (CRS)
- Standard Ash Magadi (SAM)
APPLICATIONS
Overview
Agriculture
Animal nutrition
Chemicals
Construction
Food & nutrition
Glass
High Performance Rubber
Metals
Oral Care and Cosmetics
Paints, Inks and Adhesives
Pharmaceuticals
Safety and environment
Soaps and detergents
Textiles and leather
Lithium-ion, dry cell and other batteries
Other
SUSTAINABILITY
INVESTORS
Overview
Financial information
Governance
AGM documents
Investor resources
Stock exchange communication
Other information
CAREERS
WORKING WITH US
Overview
Asia
North america
Africa
Europe
NEWSROOM
Overview
Press releases
Interviews
Articles
Events
Media reports
Media kit
Social Media
TCL Tube
Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020
IN THIS SECTION
IN THIS SECTION
Notice for board meeting - Q4 results
Quarterly CG reports
Shareholding pattern
Retirement of Mr. R. Gopalakrishnan as non-executive director and vice chairman of the company
Appointment of Bhaskar Bhat as an additional director
Presentation for Analysts' call - 08 February 2017
Temporary shutdown of Babrala plant
IEPF Advertisement - for Transfer of Shares to Investor Education and Protection Fund (IEPF) Account
TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE
Memorandum of understanding (MOU) with Government of Andhra Pradesh
Change in Key Managerial Personnel (Chief Financial Officer) of the Company
Related Party Transactions
TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE2
Resignation of Prasad R. Menon as non-executive, non-independent director
lntimation of schedule of analyst / lnstitutional lnvestor meetinqs under the SEBI (Listino obliqations and disclosure requirements) requlations. 2015
Regulation 29 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 (LODR) regulations
Details of non-convertible debentures for the half year ended March 31, 2016
Appointment of Dr Nirmalya Kumar as an additional director
Appointment of John Mulhall as the chief financial officer and key managerial personnel of the company
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Analysts call - 20th September, 2017
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Board Meeting - 6th February, 2018
Rescheduled Bord Meeting 6th May, 2018
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Completion of acquisition of precipitated silica business of Allied Silica Limited
Intimation of change in Segment Reporting of Tata Chemicals Limited under Regulation 30 of the SEBI Listing Regulations
Intimation of the Record Date pursuant to Regulation 42 of SEBI LODR Regulations
Newspaper Advertisement of Notice of the Meeting of the Equity Shareholders of Tata Chemicals Limited to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 50(1) and 60(2) of SEBI Listing Regulations of Record Date and Payment of Interest Date
Intimation under Regulation 30 of SEBI Listing Regulations for transfer of Ordinary Shares of the Company to Investor Education and Protection Fund
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the Board Meeting dated August 5, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
Confirmation by Tata Chemicals on non-applicability of SEBI Circular dated November 26, 2018 w.r.t. Large Corporates
Resignation of Dr Vijay L Kelkar, non-executive independent director
MoU with Sanjana Cryogenics Storage Ltd
Retirement of PK Ghose, executive director and CFO
Intimation for appointment of Mr. Rajiv Dube as an Independent Director
Clarification/confirmation on the news item appearing in Economic Times captioned ‘Tata Chemicals in advanced talks to buy debt-laden Archean unit’
Regulation 30 (5) of the listing regulations
Intimation under regulation 30 of the SEBI (Listing obligations and disclosure requirements) regulations, 2015
Intimation under regulation 30 of the SEBI
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations - 30 March 2016
Schedule of analyst / institutional investor meeting
Babrala plant operations resumed
Intimation to the exchange pursuant to regulation 57(2) of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
Metahelix has entered into a joint venture with Mr Suresh Gobindram Vaswani
Details of nonconvertible debentures for the half vear ended March 31, 2016
Outcome of board meeting in accordance with the SEBI (Listing obliqations and disclosure requirements) regulations, 2015
Intimation of schedule of analyst/ institutional investor meetings
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations
Board meeting notice for quarterly results 05 August 2016
Intimation of schedule of analyst/ institutional investor meetings - 23 August 2016
Replacement of Mr Cyrus P Mistry as Chairman of Tata Sons Limited with Mr Ratan N. Tata as interim Chairman of Tata Sons Limited
Review of credit rating - NCD of Rs250 crore
Investor meeting - 31 August 2016
Crisil rating
Resignation of Dr Nirmalya Kumar, non-executive director
NSE Email and Letter dated October 27, 2016 on News Clarification
MoU with Sanjana cryogenics - 12 September 2016
Eknath Kshirsagar retirement
Analysts call announcement November 11, 2016
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Resignation of Mr Bhaskar Bhat, non-executive, non independent director
Investor call intimation - 12 September 2016
Disclosure under Regulation 30 of the SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
Analysts call announcement November 16, 2016
Analysts call announcement November 21-22, 2016
Outcome of the Board Meeting November 22, 2016
Analysts call announcement November 25, 2016
Notice of extraordinary general meeting - December 23, 2016
Analysts call announcement December 5, 2016
Notice of motion
Representation of Mr Nusli N Wadia - Stock exchange letter
Notice of motion number 3504
Representation of Mr Cyrus P Mistry - Stock exchange letter
Resignation of Mr Cyrus P Mistry as Director
Proceedings and voting results of the extra general meeting - 23 December 2016
Change in board of directors
Credit ratings
Credit Rating - Non-Convertible Debenture (NCD) of Rs. 250 crores
Board meeting notice for quarterly results - 08 February 2017
Outcome of the Board Meeting - 08 February 2017
Press Release on Financial Results for the Q3 and nine months ended December 31, 2016
Regulation 30 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - Outcome of the Board Meeting - 08 February 2017
SE Analyst Meet - Intimation of schedule of analyst
SE Letter Haldia - Intimation under regulation 30 of the SEBI
lnstitutional lnvestor Meetings uncler the SEBI Requlations, 2015
Institutional Investor Meetings under the SEBI Requlations, 2015
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Institutional Investor Meetinqs under the SEBI (LODR) Requlations, 2015
Institutional Investor Meetings under the SEBI Requlations, 2015
Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015
Newspaper Advertisement of Equity Shareholders Meeting
Board Meeting
SE letter BTA Unnati Inorganics - Intimation under regulation 30 of the SEBI
Outcome of board meeting in accordance with the SEBI (Listing obligations and disclosure requirements) regulations, 2015
Submission of presentation made to Analysts / Investors
Undertaking for the year ended 31st March, 2017 under Regulation 57 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
Details of Non-Convertible Debentures for the year ended March 31, 2017
Audited results for the Press Release for the year ended March 31, 2017
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Certilication under Regulation 57(l) of the SEBI (LODR) Regulations' 2015
Regulation 29 (1) (a) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - regulations of the Board Meeting - 08 August 2017
Regulation 30 of the SEBI, LODR 2015 - Unnati Inorganics Private Limited - Cancellation of Transaction
Outcome of Board Meeting for Q1 Results of FY 2017-18
Press Release for Q1 Results of FY 2017-18
Analysts Presentation for Q1 Results of FY 2017-18
Annual Report 2016-17 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Analysts call - 12th September, 2017
Proposed Sale of equity shares of Tata Global Beverages Limited
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Sale of equity shares of Tata Global Beverages Limited
Analysts call on 26th September, 2017
Newspaper publication of notice of meeting of board of directors - Navshakti
Newspaper publication of notice of meeting of board of directors - Business Standard
Intimation for Sale of Phosphatic Business
Press Release for Sale of Phosphatic Fertilisers Business
Press Release for Q2 Results dated 13.11.2017 of FY 2017-18
Analysts Presentation for Q2 Results dated 13.11.2017 of FY 2017-18
Outcome of Board Meeting dated 13.11.2017 for Q2 Results of FY 2017-18
Certificate under Regulation 52(4) & 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2017.
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - English
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sanction of Scheme of Arrangement for the transfer of the business of Urea and customized fertilisers located at Babrala, Uttar Pradesh to Yara Fertilisers India Private Limited by NCLT, Mumbai Bench, Mumbai
Intimation of incorporation of new wholly owned subsidiary under Section 8 of the Companies Act, 2013
Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice
Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot 2017
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Completion of Sale and Transfer of Urea and Customized Fertilisers Business to Yara Fertilisers India Private Limited (“Yara”)
Outcome of Board Meeting dated 06.02.2018 for Q3 Results of FY 2017-18
Press Release for Q3 Results dated 06.02.2018 of FY 2017-18
Analysts Presentation for Q3 Results dated 06.02.2018 of FY 2017-18
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation under Regulation 30 - Appointment of Directors
lntimation under Reoulation 30 of the SEBI (Listinq Obliqations and Disclosure Requirements) Requlations. 2015
Intimation - Corrigendum to intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulation 30 as 'BTA with ASL'
Notice of Board Meeting - 7th May, 2018
Postponement of Board Meeting to be held on May 7, 2018
Notice for potponement of Board Meeting- English
Notice for postponement of Board Meeting- Marathi
Analysts' Call on Audited Financial Results for the year ended 31st March 2018
Outcome of Board Meeting held on February 5, 2019 - Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting dated May 18, 2018 approving the Standalone and Consolidated Financial Results for FY 2017-18 and declaration of Dividend.
Press Release dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Intimation under Regulation 30 of SEBI Listing Regulations regarding re-appointment of Mr. R. Mukundan as Managing Director and CEO.
Undertaking for the year ended March 31, 2018 pursuant to Regulation 57 of SEBI Listing Regulations
Details of Non-convertible Debentures for the year ended March 31, 2018 pursuant to Regulation 52(4) and 52(5) of SEBI Listing Regulations
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (NSE)
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (BSE)
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018) - Marathi
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018 - English
Intimation under Regulation 30 of SEBI Listing Regulations for sale and disposal of Phosphatic Fertilisers business and the Trading business to IRC Agrochemicals Private Limited effective June 1, 2018
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of 79th Annual General Meeting
Intimation under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for notice of 79th AGM and Book Closure dates
Intimation under Reg. 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Payment of Annual Interest to Debentureholders
Stock Exchange Intimation for the Board Meeting of the Company to be held on May 3, 2023
Webcast of 79th Annual General Meeting
Outcome of the 79th Annual General Meeting
Notice of Board Meeting - August 13, 2018
Newspaper publication of notice of meeting of Board of Directors - Marathi
Newspaper publication of notice of meeting of Board of Directors - English
Presentation on the Analyst Call
lntimation under Regulations 30 and 33 of SEBI (Listinq Obligations and Disclosure Requirements) Regulations. 2015
Press Release on the Financial Results for the quarter ended June 30, 2018
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - English
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
Newspaper publication of notice of meeting of Board of Directors (02.11.2018) - English & Marathi
MoU signed by the Company with CSIR – CECRI (Central Electrochemical Research Institute), Karaikudi
lntimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Press Release on the Financial Results for the quarter ended September 30, 2018
Non-convertible Debentures - Compliance of Regulations 52(4), 52(5) and 52(7) of SEBI Listing Regulations for the half year ended September 30, 2018
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - Marathi
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - English
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of letter sent to shareholders holding shares in physical form for updating PAN and Bank details and converting their holdings into Demat
Intimation under Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
Newspaper publication of notice of meeting of Board of Directors (05.02.2019) - English & Marathi
Presentation on the Analyst Call
Press Release on the Financial Results for the quarter ended December 31, 2018
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - English
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of the Board Meeting to be held on May 3, 2019
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - English
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - Marathi
Outcome of Board Meeting dated May 3, 2019: Approval of Standalone and Consolidated Financial Results for FY 2018-19
Outcome of Board Meeting dated May 3, 2019: Recommendation of Dividend for FY 2018 -19
Analysts/Investor Presentation dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
Press Release dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
Newspaper Advertisement (Financial Results for quarter and year ended March 31, 2019) - Marathi
Newspaper Advertisement (Financial Results for the quarter and year ended March 31, 2019) - English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2019
Outcome of the Board Meeting held on May 15, 2019: Intimation of Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited and their respective shareholders and creditors
Intimation of Analyst / Investor Call held to discuss the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for Notice of transfer of shares to Investor Education and Protection Fund
Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Related Party Transactions for the half year ended March 31, 2019
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Company’s Registrar and Share Transfer Agent update
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Record Date and Payment of Principal, Interest and Redemption Date
Notice and Explanatory Statement of the 80th Annual General Meeting
Annual Report for FY 2018-19 under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper publication of notice of the 80th Annual General Meeting of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 57(1) of the Listing Regulations of payment of Principal along with Annual Interest to the Debentureholders of 2500 – 10% Rated Taxable Unsecured Redeemable Non-Convertible Debentures
Outcome of the 80th Annual General Meeting
Intimation under Regulation 30 of the Listing Regulations for re-appointment of Ms. Vibha Paul Rishi as an Independent Director
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by Brickwork Ratings India Private Limited
Intimation of the Board Meeting to be held on August 8, 2019
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by CARE Ratings Limited
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - Marathi
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - English
Outcome of the Board Meeting dated August 8, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the quarter ended June 30, 2019
Press Release dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
Analysts/Investor Presentation dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
Intimation of Appointment of Director under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - Marathi
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - English
Cessation of Mr. Nasser Munjee and Dr. Y. S. P. Thorat as Independent Directors of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of reappointment of Ms Vibha Paul Rishi as an Independent Director of the Company under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirement Regulations, 2015
Appointment of Dr. C V Natraj as an Independent Director of the Company
Notice of the Meeting of Equity Shareholders of Tata Chemicals Limited convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
Appointment of Mr. K.B.S. Anand as an Independent Director of the Company
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 30, 2019
Newspaper publication of Notice of the Meeting of the Board of Directors to be held on October 30, 2019 - English
Newspaper publication of notice of the Meeting of the Board of Directors to be held on October 30, 2019 - Marathi
Outcome of the Board Meeting dated October 30, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2019
Outcome of the National Company Law Tribunal Convened Meeting of Tata Chemicals Limited held on Wednesday, October 30, 2019
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - English
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 read with Schedule III of SEBI LODR - Acquisition of remaining 25% interest in Tata Chemicals (Soda Ash) Partners Holding
Disclosure received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of sanction of Scheme of Arrangement by NCLT Mumbai and Kolkata Bench
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 3, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on February 3, 2020 - English and Marathi
Rescheduling of Analyst' call on the financial results for the third quarter and nine months ended December 31, 2019
Outcome of the Board Meeting dated February 3, 2020: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the third quarter and nine months ended December 31, 2019
Press Release dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for third quarter and nine months ended December 31, 2019
Analysts/Investor Presentation dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
Stock exchange intimation of Newspaper Publication for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
Intimation for Effective Date of the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure dated February 10, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Newspaper advertisement for notice of Record Date
Disclosures dated February 18 and 19, 2020 received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015: Inter-se transfers
Disclosure dated February 27, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure dated March 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Purchase of shares by Mr. N. Chandrasekaran
Clarification on the disclosures submitted under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 28, 2020 and March 5, 2020
Disclosure dated March 17, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Shutdown/ scale down of manufacturing operations at the Company’s plants due to outbreak of Coronavirus (COVID-19)
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Resuming of manufacturing operations at the Company’s plants
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 15, 2020
Outcome of the Board Meeting dated May 15, 2020: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2020 and recommendation of Dividend
Rescheduling of Analysts' Call and Presentation to be made at the rescheduled call
Cost of Acquisition of shares of Tata Chemicals Limited and Tata Consumer Products Limited (erstwhile Tata Global Beverage Limited) as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961
Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020
Intimation of Book Closure Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 81st Annual General Meeting of the Company
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Date of 81st Annual General Meeting of the Company
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
Corrigendum to the Audited Consolidated Financial Results for the year ended March 31, 2020
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations
Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement- Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Submission of Annual Secretarial Compliance Report for the Financial Year 2019-20
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 81st Annual General Meeting
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2019-20
Newspaper Advertisement for transfer of shares to IEPF Account
Annual Disclosure by Tata Chemicals Limited being identified as a Large Corporate as on March 31, 2019
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020
Outcome of the 81st Annual General Meeting
Stock Exchange Intimation of the Board Meeting of the Company to be held on July 31, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on July 31, 2020 - English and Marathi
Outcome of the Board Meeting dated July 31, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020.
Analysts/Investors Presentation dated July 31, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter ended June 30, 2020
Press Release on Financial Results for the first quarter ended June 30, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure dated September 25, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Shifting of Investor Service Centers of Registrar and Transfer Agent of the Company
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 29, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on October 29, 2020 - English and Marathi
Outcome of the Board Meeting dated October 29, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
Press Release on Financial Results for the quarter and half year ended September 30, 2020
Analysts/Investors Presentation dated October 29, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter and half year ended September 30, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Stock exchange intimation for appointment of Mr. N. Chandrasekaran as an additional Director and Chairman of the Company
Stock exchange intimation for resignation of Mr. Bhaskar Bhat as a Director of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosures dated December 1 and December 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure dated December 7, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock exchange intimation for withdrawal of Tata Chemicals (Soda Ash) Partners from the American Natural Soda Ash Corporation (ANSAC)
Stock Exchange Intimation for the Board Meeting of the Company to be held on January 28, 2021
Newspaper publication of notice of the meeting of Board of Directors to be held on January 28, 2021 - English and Marathi
Outcome of the Board Meeting dated January 28, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
Press Release on Financial Results for the third quarter and nine months ended December 31, 2020
Analysts/Investors Presentation dated January 28, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the third quarter and nine months ended December 31, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Advertisement – Transfer of equity shares pursuant SEBI Circular dated November 6, 2018 - February 23, 2021
Shifting of registered office of Registrar and Transfer Agent of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement - Intimating change of the registered office of Registrar and Transfer Agent of the Company - TSR Darashaw Consultants Private Limited
Disclosure under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
Intimation in terms of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 pertaining to transfer of securities in physical mode
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 3, 2021
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2021 - English and Marathi
Outcome of the Board Meeting dated May 3, 2021: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2021 and recommendation of Dividend
Outcome of Board Meeting dated May 3, 2021: Recommendation of Dividend for FY 2020-21
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
Press Release dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
Analysts/Investor Presentation dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for FY 2020-21
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 82nd Annual General Meeting'
Reaffirmation of Credit Rating by CRISIL Ratings upon reduction in quantum of rated amount of Commercial Paper
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 82nd Annual General Meeting
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2020-21
Intimation under Regulation 30 - Newspaper Advertisement 'Notice of the 82nd Annual General Meeting, E-Voting and Book Closure'
Affirmation of Credit Rating by Moody’s Investors Service
Intimation under Regulation 30 Newspaper Advertisement for Transfer of Shares to IEPF on June 12, 2021
Stock Exchange Intimation for corrigendum to the Integrated Annual Report FY 2020-21
Reaffirmation of Credit Rating by CARE Ratings
Outcome of the 82nd Annual General Meeting
Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2021
Stock Exchange intimation providing details of Analysts’ Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021
Press Release on Financial Results for the first quarter ended June 30, 2021
Analysts/Investors Presentation dated August 05, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reduction in rated amount and reaffirmation of credit rating by CARE Ratings
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 27, 2021
Outcome of the Board Meeting dated October 27, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
Press Release on Financial Results for the second quarter and half-year ended September 30, 2021
Analysts/Investors Presentation dated October 27, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ended September 30, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2021
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended September 30, 2021
Disclosure of Related Party Transactions for the half year ended September 30, 2021 pursuant to Regulation 23(9) of the SEBI Listing Regulations
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 10, 2022
Outcome of the Board Meeting dated February 10, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
Analysts/Investors Presentation dated February 10, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
Press Release on Financial Results for the third quarter and nine-months ended December 31, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Affirmation of Credit Rating by Fitch Ratings
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2022
Change in name of Company’s Registrar and Transfer Agent (RTA)
Outcome of the Board Meeting dated April 29, 2022: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
Re-appointment of Statutory Auditor of the Company
Analysts/Investors Presentation dated April 29, 2022 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
Press Release on Financial Results for the fourth quarter and year ended March 31, 2022
Outcome of the Board Meeting dated April 29, 2022: Recommendation of Dividend for FY 2021-22
Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Corrigendum to the Note 5 of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
Company's reply to the clarification sought by the exchange
Stock Exchange Intimation for Annual Disclosure for Fund raising by issuance of Debt Securities by Large Entities
Stock Exchange Intimation for Initial Disclosure for Fund raising by issuance of Debt Securities by Large Entities
Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of Communication to Shareholders - Tax Deduction on Dividend
Intimation under Regulation 30 - Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reaffirmation of Credit Rating by CRISIL Ratings
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 83rd Annual General Meeting'
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Business Responsibility & Sustainability Report
Intimation for Notice and Explanatory Statement of the 83rd Annual General Meeting
Intimation for Integrated Annual Report for FY 2021-22
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the 83rd Annual General Meeting
Reaffirmation of Credit Rating by CARE Ratings
Stock Exchange Intimation for the Board Meeting of the Company to be held on August 9, 2022
Outcome of the Board Meeting dated August 9, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Press Release on Financial Results for the first quarter ended June 30, 2022
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the First Quarter ended June 30, 2022
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the quarter ended June 30, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exhange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2022
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 27, 2022
Outcome of the Board Meeting dated October 27, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
Press Release on Financial Results for the second quarter and half year ended September 30, 2022
Analyst/Investors Presentation dated October 27, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2022
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the second quarter and half year ended September 30, 2022
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for the Board Meeting of the Company to be held on February 1, 2023
Outcome of the Board Meeting dated February 1, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
Press Release on Financial Results for the third quarter and nine months ended December 31, 2022
Analyst/Investors Presentation dated February 1, 2023 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
Re-appointment of Ms. Padmini Khare Kaicker as Independent Director and Mr. Zarir Langrana as Executive Director
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Postal Ballot for re-appointment of Directors
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement – Notice of Postal Ballot and E-Voting Information
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange intimation - FITCH Ratings revises Tata Chemicals’ Outlook to Positive
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Voting Results of Postal Ballot through remote e-Voting
Analyst/Investors Presentation dated May 3, 2023 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
Press Release on Financial Results for the fourth quarter and year ended March 31, 2023
Outcome of the Board Meeting dated May 3, 2023: Recommendation of Dividend for FY 2022-23
Outcome of the Board Meeting dated May 3, 2023: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
Newspaper Advertisement - Audited Standalone and Consolidated Financial Statements for the fourth quarter and year ended March 31, 2023
Audio Recording of the Analysts/Investors Call pertaining to the Financial Results for the fourth quarter and year ended March 31, 2023
Annual General Meeting of the Company and Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Re-appointment of Director of the Company
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Intimation to the holders of physical securities to furnish PAN, shareholders KYC details and Nomination as per SEBI Circular dated March 16, 2023
Submission of Annual Secretarial Compliance Report for the Financial Year 2022-23
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 84th Annual General Meeting and Book Closure'
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Business Responsibility and Sustainability Report for the Financial Year 2022-23
Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015
Notice of the 84th Annual General Meeting (‘AGM’) of the Company for FY 2022- 23
Re-affirmation of Credit Rating by CRISIL
Intimation regarding simplification of the holding structure of the US operations of Tata Chemicals Limited
Newspaper Advertisement-Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
Outcome of the 84th Annual General Meeting
Affirmation of Credit Rating by Moody’s
Increase of shareholding in Rallis India Limited
Intimation for the Board Meeting of the Company to be held on August 7, 2023
Intimation of Re-scheduled Analyst / Institutional Investor Meeting
Outcome of the Board Meeting dated August 7, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2023
Press Release on Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Analyst/Investors Presentation dated August 7, 2023 for Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Reaffirmation of Credit Rating by CARE Ratings
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 10, 2023
Intimation for the Board Meeting of the Company to be held on November 10, 2023
Intimation under Regulation 30 of SEBI Listing Regulations – update on pending litigations
Outcome of the Board Meeting dated November 10, 2023: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2023
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023
Analyst/Investors Presentation dated November 10, 2023 for Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the second quarter and half yer ended September 30, 2023
Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Merger of Registrar & Transfer Agent i.e. TSR Consultants Private Limited with Link Intime India Private Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for the Board Meeting of the Company to be held on February 5, 2024
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 5, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the Board Meeting dated February 5, 2024: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2023
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Analyst/Investors Presentation dated February 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
FITCH Ratings affirms Tata Chemicals Limited’s credit rating at BB+ & revises Outlook to Stable
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Update on the Board Meeting to be held on April 29, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Home
Investors
Stock exchange communication
Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020
Notice for board meeting - Q4 results
Quarterly CG reports
Shareholding pattern
Retirement of Mr. R. Gopalakrishnan as non-executive director and vice chairman of the company
Appointment of Bhaskar Bhat as an additional director
Presentation for Analysts' call - 08 February 2017
Temporary shutdown of Babrala plant
IEPF Advertisement - for Transfer of Shares to Investor Education and Protection Fund (IEPF) Account
TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE
Memorandum of understanding (MOU) with Government of Andhra Pradesh
Change in Key Managerial Personnel (Chief Financial Officer) of the Company
Related Party Transactions
TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE2
Resignation of Prasad R. Menon as non-executive, non-independent director
lntimation of schedule of analyst / lnstitutional lnvestor meetinqs under the SEBI (Listino obliqations and disclosure requirements) requlations. 2015
Regulation 29 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 (LODR) regulations
Details of non-convertible debentures for the half year ended March 31, 2016
Appointment of Dr Nirmalya Kumar as an additional director
Appointment of John Mulhall as the chief financial officer and key managerial personnel of the company
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Analysts call - 20th September, 2017
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Board Meeting - 6th February, 2018
Rescheduled Bord Meeting 6th May, 2018
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Completion of acquisition of precipitated silica business of Allied Silica Limited
Intimation of change in Segment Reporting of Tata Chemicals Limited under Regulation 30 of the SEBI Listing Regulations
Intimation of the Record Date pursuant to Regulation 42 of SEBI LODR Regulations
Newspaper Advertisement of Notice of the Meeting of the Equity Shareholders of Tata Chemicals Limited to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 50(1) and 60(2) of SEBI Listing Regulations of Record Date and Payment of Interest Date
Intimation under Regulation 30 of SEBI Listing Regulations for transfer of Ordinary Shares of the Company to Investor Education and Protection Fund
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the Board Meeting dated August 5, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
Confirmation by Tata Chemicals on non-applicability of SEBI Circular dated November 26, 2018 w.r.t. Large Corporates
Resignation of Dr Vijay L Kelkar, non-executive independent director
MoU with Sanjana Cryogenics Storage Ltd
Retirement of PK Ghose, executive director and CFO
Intimation for appointment of Mr. Rajiv Dube as an Independent Director
Clarification/confirmation on the news item appearing in Economic Times captioned ‘Tata Chemicals in advanced talks to buy debt-laden Archean unit’
Regulation 30 (5) of the listing regulations
Intimation under regulation 30 of the SEBI (Listing obligations and disclosure requirements) regulations, 2015
Intimation under regulation 30 of the SEBI
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations - 30 March 2016
Schedule of analyst / institutional investor meeting
Babrala plant operations resumed
Intimation to the exchange pursuant to regulation 57(2) of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
Metahelix has entered into a joint venture with Mr Suresh Gobindram Vaswani
Details of nonconvertible debentures for the half vear ended March 31, 2016
Outcome of board meeting in accordance with the SEBI (Listing obliqations and disclosure requirements) regulations, 2015
Intimation of schedule of analyst/ institutional investor meetings
Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations
Board meeting notice for quarterly results 05 August 2016
Intimation of schedule of analyst/ institutional investor meetings - 23 August 2016
Replacement of Mr Cyrus P Mistry as Chairman of Tata Sons Limited with Mr Ratan N. Tata as interim Chairman of Tata Sons Limited
Review of credit rating - NCD of Rs250 crore
Investor meeting - 31 August 2016
Crisil rating
Resignation of Dr Nirmalya Kumar, non-executive director
NSE Email and Letter dated October 27, 2016 on News Clarification
MoU with Sanjana cryogenics - 12 September 2016
Eknath Kshirsagar retirement
Analysts call announcement November 11, 2016
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Resignation of Mr Bhaskar Bhat, non-executive, non independent director
Investor call intimation - 12 September 2016
Disclosure under Regulation 30 of the SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
Analysts call announcement November 16, 2016
Analysts call announcement November 21-22, 2016
Outcome of the Board Meeting November 22, 2016
Analysts call announcement November 25, 2016
Notice of extraordinary general meeting - December 23, 2016
Analysts call announcement December 5, 2016
Notice of motion
Representation of Mr Nusli N Wadia - Stock exchange letter
Notice of motion number 3504
Representation of Mr Cyrus P Mistry - Stock exchange letter
Resignation of Mr Cyrus P Mistry as Director
Proceedings and voting results of the extra general meeting - 23 December 2016
Change in board of directors
Credit ratings
Credit Rating - Non-Convertible Debenture (NCD) of Rs. 250 crores
Board meeting notice for quarterly results - 08 February 2017
Outcome of the Board Meeting - 08 February 2017
Press Release on Financial Results for the Q3 and nine months ended December 31, 2016
Regulation 30 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - Outcome of the Board Meeting - 08 February 2017
SE Analyst Meet - Intimation of schedule of analyst
SE Letter Haldia - Intimation under regulation 30 of the SEBI
lnstitutional lnvestor Meetings uncler the SEBI Requlations, 2015
Institutional Investor Meetings under the SEBI Requlations, 2015
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Institutional Investor Meetinqs under the SEBI (LODR) Requlations, 2015
Institutional Investor Meetings under the SEBI Requlations, 2015
Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015
Newspaper Advertisement of Equity Shareholders Meeting
Board Meeting
SE letter BTA Unnati Inorganics - Intimation under regulation 30 of the SEBI
Outcome of board meeting in accordance with the SEBI (Listing obligations and disclosure requirements) regulations, 2015
Submission of presentation made to Analysts / Investors
Undertaking for the year ended 31st March, 2017 under Regulation 57 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015
Details of Non-Convertible Debentures for the year ended March 31, 2017
Audited results for the Press Release for the year ended March 31, 2017
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015
Certilication under Regulation 57(l) of the SEBI (LODR) Regulations' 2015
Regulation 29 (1) (a) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - regulations of the Board Meeting - 08 August 2017
Regulation 30 of the SEBI, LODR 2015 - Unnati Inorganics Private Limited - Cancellation of Transaction
Outcome of Board Meeting for Q1 Results of FY 2017-18
Press Release for Q1 Results of FY 2017-18
Analysts Presentation for Q1 Results of FY 2017-18
Annual Report 2016-17 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Analysts call - 12th September, 2017
Proposed Sale of equity shares of Tata Global Beverages Limited
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Sale of equity shares of Tata Global Beverages Limited
Analysts call on 26th September, 2017
Newspaper publication of notice of meeting of board of directors - Navshakti
Newspaper publication of notice of meeting of board of directors - Business Standard
Intimation for Sale of Phosphatic Business
Press Release for Sale of Phosphatic Fertilisers Business
Press Release for Q2 Results dated 13.11.2017 of FY 2017-18
Analysts Presentation for Q2 Results dated 13.11.2017 of FY 2017-18
Outcome of Board Meeting dated 13.11.2017 for Q2 Results of FY 2017-18
Certificate under Regulation 52(4) & 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2017.
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - English
Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Sanction of Scheme of Arrangement for the transfer of the business of Urea and customized fertilisers located at Babrala, Uttar Pradesh to Yara Fertilisers India Private Limited by NCLT, Mumbai Bench, Mumbai
Intimation of incorporation of new wholly owned subsidiary under Section 8 of the Companies Act, 2013
Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice
Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot 2017
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Completion of Sale and Transfer of Urea and Customized Fertilisers Business to Yara Fertilisers India Private Limited (“Yara”)
Outcome of Board Meeting dated 06.02.2018 for Q3 Results of FY 2017-18
Press Release for Q3 Results dated 06.02.2018 of FY 2017-18
Analysts Presentation for Q3 Results dated 06.02.2018 of FY 2017-18
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation under Regulation 30 - Appointment of Directors
lntimation under Reoulation 30 of the SEBI (Listinq Obliqations and Disclosure Requirements) Requlations. 2015
Intimation - Corrigendum to intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulation 30 as 'BTA with ASL'
Notice of Board Meeting - 7th May, 2018
Postponement of Board Meeting to be held on May 7, 2018
Notice for potponement of Board Meeting- English
Notice for postponement of Board Meeting- Marathi
Analysts' Call on Audited Financial Results for the year ended 31st March 2018
Outcome of Board Meeting held on February 5, 2019 - Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting dated May 18, 2018 approving the Standalone and Consolidated Financial Results for FY 2017-18 and declaration of Dividend.
Press Release dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Intimation under Regulation 30 of SEBI Listing Regulations regarding re-appointment of Mr. R. Mukundan as Managing Director and CEO.
Undertaking for the year ended March 31, 2018 pursuant to Regulation 57 of SEBI Listing Regulations
Details of Non-convertible Debentures for the year ended March 31, 2018 pursuant to Regulation 52(4) and 52(5) of SEBI Listing Regulations
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (NSE)
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (BSE)
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018) - Marathi
Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018 - English
Intimation under Regulation 30 of SEBI Listing Regulations for sale and disposal of Phosphatic Fertilisers business and the Trading business to IRC Agrochemicals Private Limited effective June 1, 2018
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of 79th Annual General Meeting
Intimation under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for notice of 79th AGM and Book Closure dates
Intimation under Reg. 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Payment of Annual Interest to Debentureholders
Stock Exchange Intimation for the Board Meeting of the Company to be held on May 3, 2023
Webcast of 79th Annual General Meeting
Outcome of the 79th Annual General Meeting
Notice of Board Meeting - August 13, 2018
Newspaper publication of notice of meeting of Board of Directors - Marathi
Newspaper publication of notice of meeting of Board of Directors - English
Presentation on the Analyst Call
lntimation under Regulations 30 and 33 of SEBI (Listinq Obligations and Disclosure Requirements) Regulations. 2015
Press Release on the Financial Results for the quarter ended June 30, 2018
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - English
Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
Newspaper publication of notice of meeting of Board of Directors (02.11.2018) - English & Marathi
MoU signed by the Company with CSIR – CECRI (Central Electrochemical Research Institute), Karaikudi
lntimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Press Release on the Financial Results for the quarter ended September 30, 2018
Non-convertible Debentures - Compliance of Regulations 52(4), 52(5) and 52(7) of SEBI Listing Regulations for the half year ended September 30, 2018
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - Marathi
Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - English
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of letter sent to shareholders holding shares in physical form for updating PAN and Bank details and converting their holdings into Demat
Intimation under Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)
Newspaper publication of notice of meeting of Board of Directors (05.02.2019) - English & Marathi
Presentation on the Analyst Call
Press Release on the Financial Results for the quarter ended December 31, 2018
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - English
Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of the Board Meeting to be held on May 3, 2019
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - English
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - Marathi
Outcome of Board Meeting dated May 3, 2019: Approval of Standalone and Consolidated Financial Results for FY 2018-19
Outcome of Board Meeting dated May 3, 2019: Recommendation of Dividend for FY 2018 -19
Analysts/Investor Presentation dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
Press Release dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
Newspaper Advertisement (Financial Results for quarter and year ended March 31, 2019) - Marathi
Newspaper Advertisement (Financial Results for the quarter and year ended March 31, 2019) - English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2019
Outcome of the Board Meeting held on May 15, 2019: Intimation of Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited and their respective shareholders and creditors
Intimation of Analyst / Investor Call held to discuss the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for Notice of transfer of shares to Investor Education and Protection Fund
Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Related Party Transactions for the half year ended March 31, 2019
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Company’s Registrar and Share Transfer Agent update
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Record Date and Payment of Principal, Interest and Redemption Date
Notice and Explanatory Statement of the 80th Annual General Meeting
Annual Report for FY 2018-19 under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper publication of notice of the 80th Annual General Meeting of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 57(1) of the Listing Regulations of payment of Principal along with Annual Interest to the Debentureholders of 2500 – 10% Rated Taxable Unsecured Redeemable Non-Convertible Debentures
Outcome of the 80th Annual General Meeting
Intimation under Regulation 30 of the Listing Regulations for re-appointment of Ms. Vibha Paul Rishi as an Independent Director
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by Brickwork Ratings India Private Limited
Intimation of the Board Meeting to be held on August 8, 2019
Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by CARE Ratings Limited
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - Marathi
Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - English
Outcome of the Board Meeting dated August 8, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the quarter ended June 30, 2019
Press Release dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
Analysts/Investor Presentation dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019
Intimation of Appointment of Director under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - Marathi
Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - English
Cessation of Mr. Nasser Munjee and Dr. Y. S. P. Thorat as Independent Directors of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of reappointment of Ms Vibha Paul Rishi as an Independent Director of the Company under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirement Regulations, 2015
Appointment of Dr. C V Natraj as an Independent Director of the Company
Notice of the Meeting of Equity Shareholders of Tata Chemicals Limited convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench
Appointment of Mr. K.B.S. Anand as an Independent Director of the Company
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 30, 2019
Newspaper publication of Notice of the Meeting of the Board of Directors to be held on October 30, 2019 - English
Newspaper publication of notice of the Meeting of the Board of Directors to be held on October 30, 2019 - Marathi
Outcome of the Board Meeting dated October 30, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2019
Outcome of the National Company Law Tribunal Convened Meeting of Tata Chemicals Limited held on Wednesday, October 30, 2019
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - English
Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - Marathi
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 read with Schedule III of SEBI LODR - Acquisition of remaining 25% interest in Tata Chemicals (Soda Ash) Partners Holding
Disclosure received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of sanction of Scheme of Arrangement by NCLT Mumbai and Kolkata Bench
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 3, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on February 3, 2020 - English and Marathi
Rescheduling of Analyst' call on the financial results for the third quarter and nine months ended December 31, 2019
Outcome of the Board Meeting dated February 3, 2020: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the third quarter and nine months ended December 31, 2019
Press Release dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for third quarter and nine months ended December 31, 2019
Analysts/Investor Presentation dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
Stock exchange intimation of Newspaper Publication for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019
Intimation for Effective Date of the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure dated February 10, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Newspaper advertisement for notice of Record Date
Disclosures dated February 18 and 19, 2020 received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015: Inter-se transfers
Disclosure dated February 27, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure dated March 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Purchase of shares by Mr. N. Chandrasekaran
Clarification on the disclosures submitted under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 28, 2020 and March 5, 2020
Disclosure dated March 17, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Shutdown/ scale down of manufacturing operations at the Company’s plants due to outbreak of Coronavirus (COVID-19)
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Resuming of manufacturing operations at the Company’s plants
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 15, 2020
Outcome of the Board Meeting dated May 15, 2020: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2020 and recommendation of Dividend
Rescheduling of Analysts' Call and Presentation to be made at the rescheduled call
Cost of Acquisition of shares of Tata Chemicals Limited and Tata Consumer Products Limited (erstwhile Tata Global Beverage Limited) as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961
Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020
Intimation of Book Closure Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 81st Annual General Meeting of the Company
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Date of 81st Annual General Meeting of the Company
Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
Corrigendum to the Audited Consolidated Financial Results for the year ended March 31, 2020
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations
Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement- Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Submission of Annual Secretarial Compliance Report for the Financial Year 2019-20
Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 81st Annual General Meeting
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2019-20
Newspaper Advertisement for transfer of shares to IEPF Account
Annual Disclosure by Tata Chemicals Limited being identified as a Large Corporate as on March 31, 2019
Disclosure regarding impact of Covid-19 pandemic on the Company’s operations - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020
Outcome of the 81st Annual General Meeting
Stock Exchange Intimation of the Board Meeting of the Company to be held on July 31, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on July 31, 2020 - English and Marathi
Outcome of the Board Meeting dated July 31, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020.
Analysts/Investors Presentation dated July 31, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter ended June 30, 2020
Press Release on Financial Results for the first quarter ended June 30, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure dated September 25, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Shifting of Investor Service Centers of Registrar and Transfer Agent of the Company
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 29, 2020
Newspaper publication of notice of the meeting of Board of Directors to be held on October 29, 2020 - English and Marathi
Outcome of the Board Meeting dated October 29, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
Press Release on Financial Results for the quarter and half year ended September 30, 2020
Analysts/Investors Presentation dated October 29, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter and half year ended September 30, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Stock exchange intimation for appointment of Mr. N. Chandrasekaran as an additional Director and Chairman of the Company
Stock exchange intimation for resignation of Mr. Bhaskar Bhat as a Director of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosures dated December 1 and December 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Disclosure dated December 7, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock exchange intimation for withdrawal of Tata Chemicals (Soda Ash) Partners from the American Natural Soda Ash Corporation (ANSAC)
Stock Exchange Intimation for the Board Meeting of the Company to be held on January 28, 2021
Newspaper publication of notice of the meeting of Board of Directors to be held on January 28, 2021 - English and Marathi
Outcome of the Board Meeting dated January 28, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
Press Release on Financial Results for the third quarter and nine months ended December 31, 2020
Analysts/Investors Presentation dated January 28, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020
Stock Exchange Intimation for Newspaper Publication of Financial Results for the third quarter and nine months ended December 31, 2020
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Advertisement – Transfer of equity shares pursuant SEBI Circular dated November 6, 2018 - February 23, 2021
Shifting of registered office of Registrar and Transfer Agent of the Company
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement - Intimating change of the registered office of Registrar and Transfer Agent of the Company - TSR Darashaw Consultants Private Limited
Disclosure under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
Intimation in terms of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 pertaining to transfer of securities in physical mode
Stock Exchange Intimation of the Board Meeting of the Company to be held on May 3, 2021
Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2021 - English and Marathi
Outcome of the Board Meeting dated May 3, 2021: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2021 and recommendation of Dividend
Outcome of Board Meeting dated May 3, 2021: Recommendation of Dividend for FY 2020-21
Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations
Press Release dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
Analysts/Investor Presentation dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for FY 2020-21
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021
Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 82nd Annual General Meeting'
Reaffirmation of Credit Rating by CRISIL Ratings upon reduction in quantum of rated amount of Commercial Paper
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 82nd Annual General Meeting
Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2020-21
Intimation under Regulation 30 - Newspaper Advertisement 'Notice of the 82nd Annual General Meeting, E-Voting and Book Closure'
Affirmation of Credit Rating by Moody’s Investors Service
Intimation under Regulation 30 Newspaper Advertisement for Transfer of Shares to IEPF on June 12, 2021
Stock Exchange Intimation for corrigendum to the Integrated Annual Report FY 2020-21
Reaffirmation of Credit Rating by CARE Ratings
Outcome of the 82nd Annual General Meeting
Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2021
Stock Exchange intimation providing details of Analysts’ Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021
Press Release on Financial Results for the first quarter ended June 30, 2021
Analysts/Investors Presentation dated August 05, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reduction in rated amount and reaffirmation of credit rating by CARE Ratings
Stock Exchange Intimation of the Board Meeting of the Company to be held on October 27, 2021
Outcome of the Board Meeting dated October 27, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
Press Release on Financial Results for the second quarter and half-year ended September 30, 2021
Analysts/Investors Presentation dated October 27, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ended September 30, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2021
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended September 30, 2021
Disclosure of Related Party Transactions for the half year ended September 30, 2021 pursuant to Regulation 23(9) of the SEBI Listing Regulations
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of the Board Meeting of the Company to be held on February 10, 2022
Outcome of the Board Meeting dated February 10, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
Analysts/Investors Presentation dated February 10, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021
Press Release on Financial Results for the third quarter and nine-months ended December 31, 2021
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2021
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Affirmation of Credit Rating by Fitch Ratings
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2022
Change in name of Company’s Registrar and Transfer Agent (RTA)
Outcome of the Board Meeting dated April 29, 2022: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
Re-appointment of Statutory Auditor of the Company
Analysts/Investors Presentation dated April 29, 2022 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022
Press Release on Financial Results for the fourth quarter and year ended March 31, 2022
Outcome of the Board Meeting dated April 29, 2022: Recommendation of Dividend for FY 2021-22
Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Corrigendum to the Note 5 of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022
Company's reply to the clarification sought by the exchange
Stock Exchange Intimation for Annual Disclosure for Fund raising by issuance of Debt Securities by Large Entities
Stock Exchange Intimation for Initial Disclosure for Fund raising by issuance of Debt Securities by Large Entities
Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation of Communication to Shareholders - Tax Deduction on Dividend
Intimation under Regulation 30 - Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reaffirmation of Credit Rating by CRISIL Ratings
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 83rd Annual General Meeting'
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for Business Responsibility & Sustainability Report
Intimation for Notice and Explanatory Statement of the 83rd Annual General Meeting
Intimation for Integrated Annual Report for FY 2021-22
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the 83rd Annual General Meeting
Reaffirmation of Credit Rating by CARE Ratings
Stock Exchange Intimation for the Board Meeting of the Company to be held on August 9, 2022
Outcome of the Board Meeting dated August 9, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Press Release on Financial Results for the first quarter ended June 30, 2022
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the First Quarter ended June 30, 2022
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the quarter ended June 30, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exhange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2022
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for the Board Meeting of the Company to be held on October 27, 2022
Outcome of the Board Meeting dated October 27, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
Press Release on Financial Results for the second quarter and half year ended September 30, 2022
Analyst/Investors Presentation dated October 27, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022
Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2022
Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the second quarter and half year ended September 30, 2022
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2022
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for the Board Meeting of the Company to be held on February 1, 2023
Outcome of the Board Meeting dated February 1, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
Press Release on Financial Results for the third quarter and nine months ended December 31, 2022
Analyst/Investors Presentation dated February 1, 2023 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022
Re-appointment of Ms. Padmini Khare Kaicker as Independent Director and Mr. Zarir Langrana as Executive Director
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022
Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Notice of Postal Ballot for re-appointment of Directors
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement – Notice of Postal Ballot and E-Voting Information
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange intimation - FITCH Ratings revises Tata Chemicals’ Outlook to Positive
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Voting Results of Postal Ballot through remote e-Voting
Analyst/Investors Presentation dated May 3, 2023 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
Press Release on Financial Results for the fourth quarter and year ended March 31, 2023
Outcome of the Board Meeting dated May 3, 2023: Recommendation of Dividend for FY 2022-23
Outcome of the Board Meeting dated May 3, 2023: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023
Newspaper Advertisement - Audited Standalone and Consolidated Financial Statements for the fourth quarter and year ended March 31, 2023
Audio Recording of the Analysts/Investors Call pertaining to the Financial Results for the fourth quarter and year ended March 31, 2023
Annual General Meeting of the Company and Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Re-appointment of Director of the Company
Communication to Shareholders - Intimation on Tax Deduction on Dividend
Intimation to the holders of physical securities to furnish PAN, shareholders KYC details and Nomination as per SEBI Circular dated March 16, 2023
Submission of Annual Secretarial Compliance Report for the Financial Year 2022-23
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 84th Annual General Meeting and Book Closure'
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Business Responsibility and Sustainability Report for the Financial Year 2022-23
Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015
Notice of the 84th Annual General Meeting (‘AGM’) of the Company for FY 2022- 23
Re-affirmation of Credit Rating by CRISIL
Intimation regarding simplification of the holding structure of the US operations of Tata Chemicals Limited
Newspaper Advertisement-Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)
Outcome of the 84th Annual General Meeting
Affirmation of Credit Rating by Moody’s
Increase of shareholding in Rallis India Limited
Intimation for the Board Meeting of the Company to be held on August 7, 2023
Intimation of Re-scheduled Analyst / Institutional Investor Meeting
Outcome of the Board Meeting dated August 7, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2023
Press Release on Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Analyst/Investors Presentation dated August 7, 2023 for Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Reaffirmation of Credit Rating by CARE Ratings
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 10, 2023
Intimation for the Board Meeting of the Company to be held on November 10, 2023
Intimation under Regulation 30 of SEBI Listing Regulations – update on pending litigations
Outcome of the Board Meeting dated November 10, 2023: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2023
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023
Analyst/Investors Presentation dated November 10, 2023 for Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the second quarter and half yer ended September 30, 2023
Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Merger of Registrar & Transfer Agent i.e. TSR Consultants Private Limited with Link Intime India Private Limited
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation for the Board Meeting of the Company to be held on February 5, 2024
Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 5, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of the Board Meeting dated February 5, 2024: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2023
Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Analyst/Investors Presentation dated February 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
FITCH Ratings affirms Tata Chemicals Limited’s credit rating at BB+ & revises Outlook to Stable
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stock Exchange Intimation for Update on the Board Meeting to be held on April 29, 2024
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015